BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28345552)

  • 1. Relationship between Hepatitis C Virus Infection and Iron Overload.
    Zou DM; Sun WL
    Chin Med J (Engl); 2017 Apr; 130(7):866-871. PubMed ID: 28345552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection.
    Hendy OM; Allam M; Allam A; Attia MH; El Taher S; Eldin MM; Ali A
    Egypt J Immunol; 2010; 17(2):33-44. PubMed ID: 23082485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low hepcidin triggers hepatic iron accumulation in patients with hepatitis C.
    Hörl WH; Schmidt A
    Nephrol Dial Transplant; 2014 Jun; 29(6):1141-4. PubMed ID: 24286977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in the iron homeostasis network: A driving force for macrophage-mediated hepatitis C virus persistency.
    Foka P; Dimitriadis A; Karamichali E; Kyratzopoulou E; Giannimaras D; Koskinas J; Varaklioti A; Mamalaki A; Georgopoulou U
    Virulence; 2016 Aug; 7(6):679-90. PubMed ID: 27058404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of translation initiation factors might be the potential therapeutic targets for HCV patients with hepatic iron overload.
    Liu Y; An D; Sun R; Jin L; Wang Q
    Med Hypotheses; 2012 Jan; 78(1):142-3. PubMed ID: 22047986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus-infected liver.
    Kohjima M; Yoshimoto T; Enjoji M; Fukushima N; Fukuizumi K; Nakamura T; Kurokawa M; Fujimori N; Sasaki Y; Shimonaka Y; Murata Y; Koyama S; Kawabe K; Haraguchi K; Sumida Y; Harada N; Kato M; Kotoh K; Nakamuta M
    World J Gastroenterol; 2015 Mar; 21(11):3291-9. PubMed ID: 25805936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commentary: Iron metabolism in hepatitis C infection.
    Roeckel IE
    Ann Clin Lab Sci; 2000 Apr; 30(2):163-5. PubMed ID: 10807159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone morphogenetic protein-binding endothelial regulator of liver sinusoidal endothelial cells induces iron overload in a fatty liver mouse model.
    Hasebe T; Tanaka H; Sawada K; Nakajima S; Ohtake T; Fujiya M; Kohgo Y
    J Gastroenterol; 2017 Mar; 52(3):341-351. PubMed ID: 27364348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron regulator hepcidin exhibits antiviral activity against hepatitis C virus.
    Liu H; Trinh TL; Dong H; Keith R; Nelson D; Liu C
    PLoS One; 2012; 7(10):e46631. PubMed ID: 23110054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of iatrogenic iron overload on the course of hepatitis C in the dialysis population: A plea for caution.
    Rostoker G; Vaziri ND
    Hemodial Int; 2017 Jun; 21 Suppl 1():S68-S77. PubMed ID: 28332306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of hepatitis C virus translation initiation by iron: role of eIF3 and La protein.
    Wang Q; Liu Y; An D; Diao H; Xu W; He X; Sun R; Wei L; Li L
    Virus Res; 2012 Aug; 167(2):302-9. PubMed ID: 22634302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of hepcidin upregulation and proteolytic cleavage of ferroportin 1 in hepatitis C virus-induced iron accumulation.
    Ohta K; Ito M; Chida T; Nakashima K; Sakai S; Kanegae Y; Kawasaki H; Aoshima T; Takabayashi S; Takahashi H; Kawata K; Shoji I; Sawasaki T; Suda T; Suzuki T
    PLoS Pathog; 2023 Aug; 19(8):e1011591. PubMed ID: 37585449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HCV and HGV infection, iron overload and liver disease in multitransfused patients with thalassaemia and persistently normal or abnormal transaminase levels.
    Gamberini MR; Francesconi R; Fortini M; Cavazzini L; Lari F; Scapoli C; Ballardini G; De Sanctis V; Bianchi FB
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():259-66. PubMed ID: 16462707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepcidin is directly regulated by insulin and plays an important role in iron overload in streptozotocin-induced diabetic rats.
    Wang H; Li H; Jiang X; Shi W; Shen Z; Li M
    Diabetes; 2014 May; 63(5):1506-18. PubMed ID: 24379355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of hemochromatosis genes in chronic hepatitis C.
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R; Baldassarre R
    Clin Ter; 2006; 157(1):61-8. PubMed ID: 16669553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duodenal ferroportin is up-regulated in patients with chronic hepatitis C.
    Ma L; Zou T; Yuan Y; Lv J; Dong X; Yang G; Zhu Y; Luo J; Zhang Z; Yang J
    PLoS One; 2014; 9(10):e110658. PubMed ID: 25330009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron overload and glucose abnormalities in chronic hepatitis C virus infection: phlebotomy lowers risk of new-onset diabetes.
    Mifuji-Moroka R; Iwasa M; Miyachi H; Sugimoto R; Tanaka H; Ishihara T; Fujita N; Kaito M; Kobayashi Y; Takei Y
    Hepatogastroenterology; 2013 Oct; 60(127):1736-41. PubMed ID: 24634944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spike-in SILAC proteomic approach reveals the vitronectin as an early molecular signature of liver fibrosis in hepatitis C infections with hepatic iron overload.
    Montaldo C; Mattei S; Baiocchini A; Rotiroti N; Del Nonno F; Pucillo LP; Cozzolino AM; Battistelli C; Amicone L; Ippolito G; van Noort V; Conigliaro A; Alonzi T; Tripodi M; Mancone C
    Proteomics; 2014 May; 14(9):1107-15. PubMed ID: 24616218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with chronic hepatitis C achieving a sustained virological response to peginterferon and ribavirin therapy recover from impaired hepcidin secretion.
    Fujita N; Sugimoto R; Motonishi S; Tomosugi N; Tanaka H; Takeo M; Iwasa M; Kobayashi Y; Hayashi H; Kaito M; Takei Y
    J Hepatol; 2008 Nov; 49(5):702-10. PubMed ID: 18620776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription.
    Nishina S; Hino K; Korenaga M; Vecchi C; Pietrangelo A; Mizukami Y; Furutani T; Sakai A; Okuda M; Hidaka I; Okita K; Sakaida I
    Gastroenterology; 2008 Jan; 134(1):226-38. PubMed ID: 18166355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.